Skip to main content

DEA Required Training on Opioid Prescribing

As medical providers we have a goal of reducing pain and suffering. To achieve that goal we use opioid analgesics, non-opioid analgesics, and other modalities. This program will discuss the indications, contraindications, benefits, and risks of various forms of analgesia.

Registration Fee 89.00
Course Staff
Information Of Course


Substance Abuse in the US – By the Numbers (Statistics on Overdoses and Trends) Matthew Feldman, JD
What are the Laws and What is Happening in the Courts Matthew Feldman, JD
Allodynia – What It is and How to Address It Allen Jacobs DPM
Available Guidelines on Prescribing Narcotics Allen Jacobs DPM

Identification of Patients at Risk of Developing Substance Use Disorders Stewart Wasser MD
What is the Patient's Perspective? Richard Lawhern PhD

Understanding the Nature of Substance Use Disorders Stewart Wasser MD
Pharmacology of Opioids Michael Brody, DPM
Strategies for the Reduction of Opioid Use in the Perioperative Patient Allen Jacobs DPM

Pharmacologic Alternatives for Managing Pain Including CBD Allen Jacobs DPM
Proper Documentation When Prescribing Opioids Allen Jacobs DPM
Appropriate use of Prescription Drug Registries Michael Brody, DPM
Patient Education Patient Contracts and Patient Engagement When Prescribing Narcotics Michael Brody, DPM

What Will You Learn?

The DEA has instituted a rule that requires all healthcare providers to take 8 hours of Opioid Prescription Training to renew their DEA licenses. This is known as the MATE act.

This course satisfied the MATE act training requirement.

Refund Policy

No refunds are available for online courses

Compliance Statement

The information contained in this presentation does not establish a standard of care, nor does it constitute legal advice.

The information is for general informational purposes only and is prepared from a perspective to aid in understanding the pathology.

In accordance with the Council on Podiatric Medical Education's Standards and Requirements for Approval of Providers of Continuing Education in Podiatric Medicine, any relevant financial relationships with commercial interests of faculty, planning committee, or any others who have influence over the content of this educational activity must be disclosed to program participants. There are no conflicts of interest to disclose for this program

Disclosure Declaration

Commercial Interests: No commercial interest provided financial support for this continuing education activity.